Literature DB >> 15295794

Physicochemical, tissue distribution, and vasodilation characteristics of nitrosated serum albumin: delivery of nitric oxide in vivo.

Hidemasa Katsumi1, Makiya Nishikawa, Shen-Feng Ma, Fumiyoshi Yamashita, Mitsuru Hashida.   

Abstract

Conjugates of nitric oxide (NO) to serum albumins are candidates for controlled delivery of NO in vivo, but their physicochemical and tissue distribution characteristics have hardly been examined yet. In this study, to achieve its in vivo delivery, bovine serum albumin (BSA) was reacted with sodium nitrite to obtain NO-BSA, which had 0.25-0.28 molecules of S-nitrosothiol/BSA. In addition to cystein, other amino acid residues were modified by the reaction. The conjugation had no significant effect on the molecular weight, but reduced the electric charge and induced reversible changes in the secondary structure of BSA. After intravenous injection in mice at a dose of 1 mg/kg, 111In-NO-BSA slowly disappeared from plasma in a similar manner to 111In-BSA, but showed greater accumulation in the liver and kidney. NO-BSA induced a transient decrease in arterial pressure after intravenous injection in rats at a dose of 100 mg/kg, and significantly increased the distribution of 111In-BSA to the lung in mice. These results indicate that NO is released from NO-BSA shortly after injection, and this NO decreases blood pressure and increases the distribution of macromolecules to the lung. These findings provide useful basic information for designing macromolecular NO donors able to achieve controlled delivery of NO.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15295794     DOI: 10.1002/jps.20147

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  7 in total

1.  Stöber Synthesis of Nitric Oxide-Releasing S-Nitrosothiol-Modified Silica Particles.

Authors:  Daniel A Riccio; Julia L Nugent; Mark H Schoenfisch
Journal:  Chem Mater       Date:  2011-04-12       Impact factor: 9.811

2.  Recombinant human serum albumin dimer has high blood circulation activity and low vascular permeability in comparison with native human serum albumin.

Authors:  Sadaharu Matsushita; Victor Tuan Giam Chuang; Masanori Kanazawa; Sumio Tanase; Keiichi Kawai; Toru Maruyama; Ayaka Suenaga; Masaki Otagiri
Journal:  Pharm Res       Date:  2006-05-16       Impact factor: 4.200

3.  S-nitrosothiol-modified dendrimers as nitric oxide delivery vehicles.

Authors:  Nathan A Stasko; Thomas H Fischer; Mark H Schoenfisch
Journal:  Biomacromolecules       Date:  2008-02-05       Impact factor: 6.988

4.  In vivo pharmacological activity and biodistribution of S-nitrosophytochelatins after intravenous and intranasal administration in mice.

Authors:  Lamia Heikal; Anna Starr; Gary P Martin; Manasi Nandi; Lea Ann Dailey
Journal:  Nitric Oxide       Date:  2016-06-24       Impact factor: 4.427

5.  Superoxide dismutase as a novel macromolecular nitric oxide carrier: preparation and characterization.

Authors:  Ssu-Han Chen; Shih-Jiuan Chiu; Teh-Min Hu
Journal:  Int J Mol Sci       Date:  2012-10-29       Impact factor: 5.923

6.  Molecular Design of Bisphosphonate-Modified Proteins for Efficient Bone Targeting In Vivo.

Authors:  Hidemasa Katsumi; Jun-Ichi Sano; Makiya Nishikawa; Keiko Hanzawa; Toshiyasu Sakane; Akira Yamamoto
Journal:  PLoS One       Date:  2015-08-19       Impact factor: 3.240

Review 7.  Exogenous NO Therapy for the Treatment and Prevention of Atherosclerosis.

Authors:  Tommaso Gori
Journal:  Int J Mol Sci       Date:  2020-04-13       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.